Literature DB >> 19128274

ASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring.

Thomas G Pickering1, William B White.   

Abstract

Entities:  

Year:  2008        PMID： 19128274      PMCID： PMC8672981          DOI： 10.1111/j.1751-7176.2008.00043.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  28 in total

1.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

2.  Ambulatory blood-pressure monitoring in clinical practice.

Authors:  William B White
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

3.  Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.

Authors:  Kristina Björklund; Lars Lind; Björn Zethelius; Bertil Andrén; Hans Lithell
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy.

Authors:  George S Stergiou; Nikolaos M Baibas; Alexandra P Gantzarou; Irini I Skeva; Chrysa B Kalkana; Leonidas G Roussias; Theodore D Mountokalakis
Journal:  Am J Hypertens       Date:  2002-02       Impact factor: 2.689

5.  Self-measured home blood pressure in predicting ambulatory hypertension.

Authors:  George A Mansoor; William B White
Journal:  Am J Hypertens       Date:  2004-11       Impact factor: 2.689

6.  Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.

Authors:  W B White; G A Mansoor; T G Pickering; D G Vidt; H G Hutchinson; R B Johnson; R Noveck
Journal:  Am J Hypertens       Date:  1999-08       Impact factor: 2.689

7.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

8.  Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors:  B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

9.  The prognostic value of ambulatory blood pressures.

Authors:  D Perloff; M Sokolow; R Cowan
Journal:  JAMA       Date:  1983-05-27       Impact factor: 56.272

Review 10.  Masked hypertension: a review.

Authors:  Thomas G Pickering; Kazuo Eguchi; Kazuomi Kario
Journal:  Hypertens Res       Date:  2007-06       Impact factor: 3.872
View more
  29 in total

1.  Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

Authors:  Joel Neutel; Dean J Kereiakes; Kathy A Stoakes; Jen-Fue Maa; Ali Shojaee; William F Waverczak
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States.

Authors:  Ian M Kronish; Shia Kent; Nathalie Moise; Daichi Shimbo; Monika M Safford; Robert E Kynerd; Ronan O'Beirne; Alexandra Sullivan; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2017-07-06

3.  Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.

Authors:  Joseph Ravenell; Daichi Shimbo; John N Booth; Daniel F Sarpong; Charles Agyemang; Danielle L Beatty Moody; Marwah Abdalla; Tanya M Spruill; Amanda J Shallcross; Adam P Bress; Paul Muntner; Gbenga Ogedegbe
Journal:  Circulation       Date:  2017-04-20       Impact factor: 29.690

4.  A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Authors:  Linnea A Polgreen; Barry L Carter; Philip M Polgreen; Peter M Snyder; Daniel K Sewell; Emine O Bayman; Shelby L Francis; Jacob E Simmering; Christopher Parker; Rachel Finkelstein
Journal:  Contemp Clin Trials       Date:  2020-10-07       Impact factor: 2.226

Review 5.  Implementing ABPM into Clinical Practice.

Authors:  Alan L Hinderliter; Raven A Voora; Anthony J Viera
Journal:  Curr Hypertens Rep       Date:  2018-02-05       Impact factor: 5.369

Review 6.  The evolution and refinement of traditional risk factors for cardiovascular disease.

Authors:  Emil M deGoma; Joshua W Knowles; Fabio Angeli; Matthew J Budoff; Daniel J Rader
Journal:  Cardiol Rev       Date:  2012 May-Jun       Impact factor: 2.644

7.  Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Authors:  Amita Singh; Eugenia Gianos; Arthur Schwartzbard; Henry Black; Howard Weintraub
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

8.  Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension.

Authors:  Dena E Rifkin; Joseph A Abdelmalek; Cynthia M Miracle; Chai Low; Ryan Barsotti; Phil Rios; Carl Stepnowsky; Zia Agha
Journal:  Blood Press Monit       Date:  2013-02       Impact factor: 1.444

Review 9.  Hypertension: issues in control and resistance.

Authors:  Marion R Wofford; Deborah S Minor
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

Review 10.  Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.